Tangka Florence K L, Subramanian Sujha, Beebe Maggie Cole, Weir Hannah K, Trebino Diana, Babcock Frances, Ewing Jean
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia (Drs Tangka and Weir and Mss Babcock and Ewing); and RTI International, Waltham, Massachusetts (Drs Subramanian and Beebe and Ms Trebino). Ms Trebino is currently with Dana-Farber Cancer Institute, Boston, Massachusetts.
J Public Health Manag Pract. 2016 Sep-Oct;22(5):452-60. doi: 10.1097/PHH.0000000000000349.
The Centers for Disease Control and Prevention (CDC) evaluated the economics of the National Program of Cancer Registries to provide the CDC, the registries, and policy makers with the economics evidence-base to make optimal decisions about resource allocation. Cancer registry budgets are under increasing threat, and, therefore, systematic assessment of the cost will identify approaches to improve the efficiencies of this vital data collection operation and also justify the funding required to sustain registry operations.
To estimate the cost of cancer registry operations and to assess the factors affecting the cost per case reported by National Program of Cancer Registries-funded central cancer registries.
We developed a Web-based cost assessment tool to collect 3 years of data (2009-2011) from each National Program of Cancer Registries-funded registry for all actual expenditures for registry activities (including those funded by other sources) and factors affecting registry operations. We used a random-effects regression model to estimate the impact of various factors on cost per cancer case reported.
The cost of reporting a cancer case varied across the registries. Central cancer registries that receive high-quality data from reporting sources (as measured by the percentage of records passing automatic edits) and electronic data submissions, and those that collect and report on a large volume of cases had significantly lower cost per case. The volume of cases reported had a large effect, with low-volume registries experiencing much higher cost per case than medium- or high-volume registries.
Our results suggest that registries operate with substantial fixed or semivariable costs. Therefore, sharing fixed costs among low-volume contiguous state registries, whenever possible, and centralization of certain processes can result in economies of scale. Approaches to improve quality of data submitted and increasing electronic reporting can also reduce cost.
美国疾病控制与预防中心(CDC)对国家癌症登记计划的经济学情况进行了评估,以便为CDC、各登记机构及政策制定者提供经济学证据基础,从而在资源分配方面做出最优决策。癌症登记预算面临着与日俱增的威胁,因此,对成本进行系统评估将有助于确定提高这一重要数据收集工作效率的方法,并为维持登记工作所需的资金提供合理依据。
估算癌症登记工作的成本,并评估影响由国家癌症登记计划资助的中央癌症登记机构所报告的每例病例成本的因素。
我们开发了一个基于网络的成本评估工具,从每个由国家癌症登记计划资助的登记机构收集3年的数据(2009 - 2011年),内容涵盖登记活动的所有实际支出(包括那些由其他来源资助的支出)以及影响登记工作的因素。我们使用随机效应回归模型来估算各种因素对所报告的每例癌症病例成本的影响。
各登记机构报告一例癌症病例的成本各不相同。从报告来源接收高质量数据(以通过自动编辑的记录百分比衡量)且采用电子数据提交方式的中央癌症登记机构,以及收集和报告大量病例的机构,每例病例的成本显著更低。报告的病例数量影响很大,病例数量少的登记机构每例病例的成本比病例数量中等或多的登记机构高得多。
我们的结果表明,登记机构运营存在大量固定或半可变成本。因此,尽可能在病例数量少的相邻州登记机构之间分摊固定成本,以及对某些流程进行集中化处理,可实现规模经济。提高提交数据质量和增加电子报告的方法也可降低成本。